Opioids and the Treatment of Chronic Pain: Controversies, Current Status, and Future Directions

Experimental and Clinical Psychopharmacology

Volumn 16, Issue 5, 2008, Pages 405-416

  Rosenblum, Andrew ^a   Marsch, Lisa A ^a   Joseph, Herman ^a   Portenoy, Russell K ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

addiction; chronic pain; opiods; pain management

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CODEINE; DIAMORPHINE; FENTANYL; FENTANYL CITRATE; FENTORA; HYDROCODONE BITARTRATE PLUS IBUPROFEN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE SULFATE; OPANA; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL PLUS TRAMADOL; PERCOCET; PERCODAN; TRAMADOL; UNCLASSIFIED DRUG;

ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL PRACTICE; CONSTIPATION; DRUG ABUSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; HYPERALGESIA; LEGAL ASPECT; LONG TERM CARE; MENTAL PERFORMANCE; MIOSIS; NEUROBIOLOGY; NOMENCLATURE; PERISTALSIS; PRURITUS; RESPIRATION DEPRESSION; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; CHRONIC DISEASE; DRUG TOLERANCE; HISTORY, ANCIENT; HUMANS; NARCOTIC ANTAGONISTS; NERVOUS SYSTEM; OPIOID-RELATED DISORDERS; PAIN; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 54049132600     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0013628     Document Type: Article

References (147)

1. American Academy of Pain Medicine (APM), and American Pain Society (APS). The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clinical Journal of Pain 13 (1997) 6-8
2. Adriaensen H., Mattelaer B., and Vanmeenen H. A long-term open, clinical and pharmacokinetic assessment of sublingual buprenorphine in patients suffering from chronic pain. Acta Anaesthesiologica Belgica 36 (1985) 33-40
3. American Academy of Family Physicians, American Academy of Hospice and Palliative Medicine, American Academy of Pain Medicine, American Alliance of Cancer Pain Initiatives, American Cancer Society, and American Medical Association. Promoting pain relief and preventing abuse of pain medications: A critical balancing act. A joint statement from 21 health organizations and the Drug Enforcement Administration (1996-2002). http://www.ampainsoc.org/advocacy/promoting.htm Retrieved February 25, 2008, from http://www.ampainsoc.org/advocacy/promoting.htm
4. American Geriatric Society. The management of chronic pain in older persons. American Geriatric Society Panel on Chronic Pain in Older Persons. Geriatrics 53 (1998) S8-S24
5. American Pain Society (APS). Chronic pain in America: Roadblocks to relief (1999). http://www.ampainsoc.org/links/roadblocks/ Retrieved February 12, 2008, from http://www.ampainsoc.org/links/roadblocks/
6. American Society of Addiction Medicine (ASAM). Definitions related to the use of opioids for the treatment of pain (2001). http://www.ampainsoc.org/advocacy/opioids2.htm Retrieved February 25, 2008, from http://www.ampainsoc.org/advocacy/opioids2.htm
7. Angst M.S., and Clark J.D. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology 104 (2006) 570-587
8. Aronoff G.M. Evaluation and treatment of chronic pain (1999), Lippincott, Williams, & Wilkins, New York
9. Askitopoulou H., Ramoutsaki I.A., and Konsolaki E. Archaeological evidence on the use of opium in the Minoan world. International Congress Series 1292 (2002) 23-97
10. Ballantyne J.C. Opioids for chronic nonterminal pain. Southern Medical Journal 99 (2006) 1245-1255
11. Ballantyne J.C., and LaForge K.S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129 (2007) 235-255
12. Ballantyne J.C., and Mao J. Opioid therapy for chronic pain. New England Journal of Medicine 349 (2003) 1943-1953
13. Barkin R.L., Barkin S.J., and Barkin D.S. Propoxyphene (dextropropoxyphene): A critical review of a weak opioid analgesic that should remain in antiquity. American Journal of Therapeutics 13 (2006) 534-542
14. Beecher H.K. Relationship of significance of wound to pain experienced. Journal of the American Medical Association 161 (1959) 609-613
15. Bickel W.K., and Amass L.A. Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psvchopharmacoloqy 3 (1995) 477-489
16. Bidlack J.M. Detection and function of opioid receptors on cells from the immune system. Clinical and Diagnostic Laboratory Immunology 7 (2000) 719-723
17. Booth M. Opium: A history (1986), St. Martin's Press, New York
18. Breitbart W., Passik S., McDonald M.V., Rosenfeld B., Smith M., Kaim M., et al. Patient-related barriers to pain management in ambulatory AIDS patients. Pain 76 (1998) 9-16
19. Breitbart W., Rosenfeld B.D., Passik S.D., McDonald M.V., Thaler H., and Portenoy R.K. The undertreatment of pain in ambulatory AIDS patients. Pain 65 (1996) 239-245
20. Brennan F., Carr D.B., and Cousins M. Pain management: A fundamental human right. Anesthesia and Analgesia 105 (2007) 205-221
21. Brennan P.L., Schutte K.K., and Moos R.H. Pain and use of alcohol to manage pain: Prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction 100 (2005) 777-786
22. Butler S.F., Budman S.H., Fernandez K.C., Houle B., Benoit C., Katz N., et al. Development and validation of the current opioid misuse measure. Pain 130 (2007) 144-156
23. Chou R., Clark E., and Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: A systematic review. Journal of Pain and Symptom Management 26 (2003) 1026-1048
24. Chu L.F., Clark D.J., and Angst M.S. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. Journal of Pain 7 (2006) 43-48
25. Cicero T.J., and Inciardi J.A. Potential for abuse of buprenorphine in office-based treatment of opioid dependence. New England Journal of Medicine 353 (2005) 1863-1865
26. Cicero T.J., Inciardi J.A., and Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. Journal of Pain: Official Journal of the American Pain Society 6 (2005) 662-672
27. Cicero T.J., Surratt H.L., and Inciardi J. Use and misuse of buprenorphine in the management of opioid addiction. Journal of Opioid Management 3 (2007) 302-308
28. Collett B.J. Opioid tolerance: The clinical perspective. British Journal of Anaesthia 81 (1998) 58-68
29. Compton M.A. Cold-presser pain tolerance in opiate and cocaine abusers: correlates of drug type and use status. Journal of Pain and Symptom Management 9 (1994) 462-473
30. Compton P., Charuvastra V.C., and Ling W. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug and Alcohol Dependence 63 (2001) 139-146
31. Compton P.J., Darakjian J., and Miotto K. Screening for addiction in patients with chronic pain and problematic' substance use: Evaluation of a pilot assessment tool. Journal of Pain and Symptom Management 16 (1998) 355-363
32. Compton W.M., and Volkow N.D. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence 81 (2006) 103-107
33. Corbett A.D., Henderson G., McKnight A.T., and Paterson S.J. Seventy-five years of opioid research: The exciting but vain quest for the Holy Grail. British Journal Pharmacology 147 (2006) S153-S162
34. Courtwright D.T., Joseph H., and DesJarlais D. Addicts who survived (1989), University of Tennessee Press, Knoxville, TN
35. Covington E.C., and Kotz M.M. Psychological approaches to the management of pain. In: Graham A.W., Schulz T.K., Mayo-Smith M.F., Ries R.K., and Wilford B.B. (Eds). Principles of addiction medicine. 3rd ed. (2003), American Society of Addiction Medicine, Inc, Chevy Chase, MD 1421-1438
36. Cowan A., Lewis J.W., and Macfarlane I.R. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. British Journal of Pharmacology 60 (1977) 537-545
37. Cowan D.T., Allan L.G., Libretto S.E., and Griffiths P. Opioid drugs: A comparative survey of therapeutic and "Street" use. Pain Medicine 2 (2001) 193-203
38. CSAT (Center for Substance Abuse Treatment). Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement [Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939] (2004), Substance Abuse and Mental Health Services Administration, Rockville, MD
39. Dahan A., Yassen A., Romberg R., Sarton E., Teppema L., Olofsen E., et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. British Journal of Anesthesia 96 (2006) 627-632
40. DeLeo J.A. Basic science of pain. Journal of Bone and Joint Surgery 88A (2006) 58-62
41. DeLeo J.A., Tanga F.Y., and Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10 (2004) 40-52
42. Deshpande A., Furlan A., Mailis-Gagnon A., Atlas S., and Turk D. Opioids for chronic low-back pain. Cochrane Database System Review 3 (2007) CD004959
43. Di Chiara G. Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behavior and Brain Research 137 (2002) 75-114
44. Dikotter F., Laaman L., and Xun Z. Narcotic culture: A history of drugs in China (2004), University of Chicago Press, Chicago
45. Dworkin S.F., and Sherman J.J. Relying on objective and subjective measures of chronic pain: Guidelines for use and interpretation. In: Turk D.C., and Melzack R. (Eds). Handbook of pain assessment (2001), Guilford Press, New York 619-638
46. Eisenberg E., McNicol E.D., and Carr D.B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials. Journal of the American Medical Association 293 (2005) 3043-3052
47. Eriksen, J. (2004). Long-term/chronic non-cancer pain: Epidemiology, healthcare utilization, socioeconomy and aspects of treatment. Unpublished master's thesis, University of Copenhagen, Copenhagen.
48. Eriksen, J., Becker, N., & Sjegren, P. (2002, August). Use of opioids in chronic non-malignant pain patients treated at a multidisciplinary pain center or in general practice. Paper presented at the 10th World Congress on Pain, San Diego, CA.
49. Eriksen J., Sjøgren P., Bruera E., Ekholm O., and Rasmussen N.K. Critical issues on opioids in chronic non-cancer pain: An epidemiological study. Pain 2006 (2006) 172-179
50. Farrell M. Opiate withdrawal. Addiction 89 (1994) 1471-1475
51. Ferrell B.R., McCaffery M., and Rhiner M. Pain and addiction: An urgent need for change in nursing education. Journal of Pain Symptom Management 7 (1992) 117-124
52. Field M.J., and Cassel C.K. Approaching death: Improving care at the end of life (1997), National Academy Press, Washington, DC
53. Fine P.G., and Portenoy R.K. A clinical guide to opioid analgesia (2007), Vendome Group Health Care Division, New York
54. Fishbain D.A., Rosomoff H.L., and Rosomoff R.S. Drug abuse, dependence and addiction in chronic patients. Clinical Journal of Pain 8 (1992) 77-85
55. Fishman S.M. Pain as the fifth vital sign: How can I tell when back pain is serious. Journal of Pain & Palliative Care Pharmacotherapy 19 (2005) 77-79
56. Fordyce W.E. Behavior methods for chronic pain and illness (1976), CV Mosby, St. Louis, MO
57. Fudala P.J., Bridge T.P., Herbert S., Williford W.O., Chiang C.N., Jones K., et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. New England Journal of Medicine 349 (2003) 949-958
58. Fujimoto D., and Coluzzi P.H. Survey of analgesic use for nonmalignant pain in long-term care facilities in southern California. Journal of the American Medical Association 1 (2000) 109-113
59. Furlan A.D., Sandoval J.A., Mailis-Gagnon A., and Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. Canadian Medical Association Journal 174 (2006) 1589-1594
60. Gatchel R.J., Peng Y.B., Peters M.L., Fuchs P.N., and Turk D.C. The biopsychosocial approach to chronic pain: Scientific advances and future directions. Psychological Bulletin 133 (2007) 581-624
61. Gourlay G.K. Sustained relief of chronic pain: Pharmacokinetics of sustained release morphine. Clinical Pharmacokinetics 35 (1998) 173-190
62. Griessinger N., Sittl R., and Likar R. Transdermal buprenorphine in clinical practice-a post-marketing surveillance study in 13,179 patients. Current Medical Research and Opinion 21 (2005) 1147-1156
63. Gureje O., Simon G.E., and Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain 92 (2001) 195-200
64. Gureje O., Von Korff M., Simon G.E., and Gater R. Persistent pain and well-being: A World Health Organization study in primary care. Journal of the American Medical Association 280 (1998) 147-151
65. Handelsman L., Cochrane K.J., Aronson M.J., Ness R., Rubinstein K.J., and Kanof P.D. Two new rating scales for opiate withdrawal. American Journal of Drug and Alcohol Abuse 13 (1987) 293-308
66. Hans G. Buprenorphine: A review of its role in neuropathic pain. Journal of Opioid Management 3 (2007) 195-206
67. Heit H.A., and Gourlay D.L. Buprenorphine: New tricks with an old molecule for pain management. Clinical Journal of Pain 24 (2008) 93-97
68. Hoffmann N.G., Olofsson O., Salen B., and Wickstrom L. Prevalence of abuse and dependency in chronic pain patients. The International Journal of the Addictions 30 (1995) 919-927
69. Hosztafi S. The history of heroin. Acta Pharmaceutica Hungarica 71 (2001) 233-242
70. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., and Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 18 (1975) 577-580
71. Jaffe J.H., and Jaffe A.B. Neurobiology of opioids. In: Galanter M., and Kleber H.D. (Eds). Textbook of substance abuse treatment (2004), American Psychiatric Publishing, Washington, DC 17-30
72. Jaffe J.H., and Martin W.R. Narcotic analgesics and antagonists. In: Goodman L.S., and Gilman A. (Eds). The pharmacological basis of therapeutics (1990), Macmillan, New York 485-521
73. Jamison R.N., Kauffman J., and Katz N.P. Characteristics of methadone maintenance patients with chronic pain. Journal of Pain and Symptom Management 19 (2000) 53-62
74. Johnson R.E., Fudala P.J., and Payne R. Buprenorphine: Considerations for pain management. Journal of Pain Symptom Management 29 (2005) 297-326
75. Johnson R.E., Strain E.C., and Amass L. Buprenorphine: How to use it right. Drug and Alcohol Dependence 70 (2003) S59-77
76. Joranson D.E., Ryan K.M., Gilson A.M., and Dahl J.L. Trends in medical use and abuse of opioid analgesics. Journal of the American Medical Association 5 (2000) 1710-1714
77. Kakko J., Svanborg K.D., Kreek M.J., and Heilig M. One-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomized, placebo-controlled trial. Lancet 361 (2003) 662-668
78. Kalso E., Edwards J.E., Moore R.A., and McQuay H.J. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 112 (2004) 372-380
79. Karasz A., Zallman L., Berg K., Gourevitch M., Selwyn P., and Arnstein J.H. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. Journal of Pain Symptom Management 28 (2004) 517-525
80. Katz N.P., Adams E.H., Chilcoat H., Colucci R.D., Comer S.D., Goliber P., et al. Challenges in the development of prescription opioid abuse-deterrent formulations. Clinical Journal of Pain 23 (2007) 648-660
81. Katz N.P., Sherburne S., Beach M., Rose R.J., Vielguth J., Bradley J., et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesthesia and Analgesia 97 (2003) 1097-1102
82. Keane M. Caution with epidemiological data in relation to chronic opioid use. Pain 129 (2007) 226-227
83. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
84. Koppert W., Ihmsen H., Körber N., Wehrfritz A., Sittl R., Schmelz M., et al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain 118 (2005) 15-22
85. Koppert W., and Schmelz M. The impact of opioid-induced hyperalgesia for postoperative pain. Best Practice & Research Clinical Anaesthesiology 21 (2007) 65-83
86. Lewis J.W. Buprenorphine. Drug and Alcohol Dependence 14 (1985) 363-372
87. Lin J.J., Alfandre D., and Moore C. Physician attitudes toward opioid prescribing for patients with persistent noncancer pain. Clinical Journal of Pain 23 (2007) 799-803
88. Lue H.U., Passik S.D., and Portenoy R.K. Management of chronic pain in the patient with substance abuse. In: Aronoff G.M. (Ed). Evaluation and treatment of chronic pain (1999), Lippincott, Williams, & Wilkins, New York 421-429
89. Malinoff H.L., Barkin R.L., and Wilson G. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. American Journal of Therapeutics 12 (2005) 379-384
90. Manchikanti L. Health care reform in the United States: Radical surgery needed now more than ever. Pain Physician 11 (2008) 13-42
91. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 100 (2002) 213-217
92. Martell B.A., O'Connor P.G., Kerns R.D., Becker W.C., Morales K.H., Kosten T.R., et al. Systematic review. Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Annals of Internal Medicine 146 (2007) 116-127
93. McQuay H. Opioids in pain management. Lancet 353 (1999) 2229-2232
94. Meldrum M.L. A capsule history of pain management. Journal of the American Medical Association 290 (2003) 2470-2475
95. Melzack R. The tragedy of needless pain. Scientific American 262 (1990) 27-33
96. Musto D.F. The American disease: Origins of narcotic control. 3rd ed. (1999), Oxford University Press, New York
97. Nasar M.A., McLeavy M.A., and Knox J. An open study of sub-lingual buprenorphine in the treatment of chronic pain in the elderly. Current Medical Research and Opinion 10 (1986) 251-255
98. Noble M., Tregear S.J., Treadwell J.R., and Schoelles K. Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. Journal of Pain and Symptom Management 35 (2008) 214-228
99. Nwokeji E.D., Rascati K.L., Brown C.M., and Eisenberg A. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain. Clinical Therapeutics 29 (2007) 2589-2602
100. Nyswander M.E., and Dole V.P. On the use of methadone to limit physical dependence in the treatment of chronic pain. In: Foley K.M., and Inturrisi C.E. (Eds). Advances in pain research and therapy 8 (1986), Raven Press, New York 187-190
101. O'Connor P.G., Oliveto A.H., Shi J.M., Triffleman E.G., Carroll K.M., Kosten T.R., et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. The American Journal of Medicine 105 (1998) 100-105
102. Office of Quality Performance (OQP). Management of opioid therapy for chronic pain (2003). http://www.oqp.med.va.gov/cpg/cot/ot_base.htm Retrieved February 12, 2008, from http://www.oqp.med.va.gov/cpg/cot/ot_base.htm
103. Ohayon M.M., and Schatzberg A.F. Using chronic pain to predict depressive morbidity in the general population. Archives of General Psychiatry 60 (2003) 39-47
104. Pain Society. Recommendations for the appropriate use of opioids for persistent non-cancer pain (2004). http://www.britishpainsociety.org/pub_professional.htm#opioids Retrieved February 12, 2008, from http://www.britishpainsociety.org/pub_professional.htm#opioids
105. Passik S.D., Kirsh K.L., Donaghy K.B., and Portenoy R.K. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clinical Journal of Pain 22 (2006) 173-181
106. Passik S.D., Kirsh K.L., Whitcomb L., Portenoy R.K., Katz N.P., Kleinman L., et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clinical Therapy 26 (2004) 552-561
107. Patt R.B., and Burton A.W. Pain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain management. In: Aronoff G.M. (Ed). Evaluation and treatment of chronic pain (1998), Lippincott, Williams, & Wilkins, New York 337-376
108. Portenoy R.K. Opioid therapy for chronic non-malignant pain: Current status. In: Fields H.L., and Liebeskind J.C. (Eds). Progress in pain research and management 1 (1994), IASP, Seattle
109. Portenoy R.K., Farrar J.T., Backonja M.M., Cleeland C.S., Yang K., Friedman M., Colucci S.V., and Richards P. Long-term use of controlled-release oxycodone for noncancer pain: Results of a 3-year registry study. Clinical Journal of Pain 23 (2007) 287-299
110. Portenoy R.K., and Foley K.M. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 25 (1986) 171-186
111. Portenoy R.K., and Lesage P. Management of cancer pain. Lancet 353 (1999) 1695-7000
112. Portenoy R.K., Payne R., and Passik S.K. Acute and chronic pain. In: Lowinson J.H., Ruz P., Millman R.B., and Langrod J.G. (Eds). Substance abuse: A comprehensive textbook. 4th ed. (2004), Lippincott, Williams, & Wilkins, Philadelphia 863-904
113. Raghavendra V., Rutkowski M.D., and DeLeo J.A. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. Journal of Neuroscience 22 (2002) 9980-9989
114. Rosenblum A., Joseph H., Fong C., Kipnis S., Cleland C., and Portenoy R.K. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. Journal of the American Medical Association 289 (2003) 2370-2378
115. Rosenblum A., Parrino M., Schnoll S.H., Fong C., Maxwell C., Cleland C.M., et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence 90 (2007) 64-71
116. SAMHSA. Diversion and abuse of buprenorphine: A brief Assessment of emerging indicators (2006). http://buprenorphine.samhsa.gov/Buprenorphine_FinalReport_12.6.06.pdf Retrieved February 25, 2008, from http://buprenorphine.samhsa.gov/Buprenorphine_FinalReport_12.6.06.pdf
117. SAMHSA. ED Trends from DAWN: Final estimates 1995-2002 (2004), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD
118. SAMHSA. DASIS Report. Treatment admissions involving narcotic pain killers: 2002 update (2004). http://www.oas.samhsa.gov/2k4/painTX/painTX.htm Retrieved February 12, 2008, from http://www.oas.samhsa.gov/2k4/painTX/painTX.htm
119. Savage S.R. Long-term opioid therapy: Assessment of consequences and risks. Journal of Pain and Symptom Management 11 (1996) 274-286
120. Savage S.R. Opioid medications in the management of pain. In: Graham A.W., Shultz T.K., Mayo-Smith M.F., Ries R.K., and Wilford B.B. (Eds). Principles of addiction medicine. 3rd ed. (2003), American Society of Addiction Medicine, Chevy Chase, MD 1451-1463
121. Schiff P.L. Opium and its alkaloids. American Journal of Pharmaceutical Education 66 (2002) 186-194
122. Schnoll S.H., and Weaver M.F. Addiction and pain. American Journal of Addiction 12 (2003) 27-35
123. Scimeca M.M., Savage S.R., Portenoy R., and Lowinson J. Treatment of pain in methadone-maintained patients. Mount Sinai Journal of Medicine 67 (2000) 412-422
124. Sheu R., Lussier D., Rosenblum A., Fong C., Portenoy J., Joseph H., et al. Prevalence and Characteristics of Chronic Pain in Patients Admitted to an Outpatient Drug and Alcohol Treatment Program. Pain Medicine (2008) In press
125. Singh S., Sleeper R.B., and Seifert C.F. Propoxyphene prescribing among populations older and younger than age 65 in a tertiary care hospital. The Consultant Pharmacist: Journal of the American Society of Consultant Pharmacists 22 (2007) 141-148
126. Sittl R. Transdermal buprenorphine in the treatment of chronic pain. Expert Review of Neurotherapeutics 5 (2005) 315-323
127. Sittl R., Nuijten M., and Nautrup B.P. Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: A retrospective data analysis in Germany. Clinical Therapeutics 28 (2006) 1144-1154
128. Smith M.Y., Bailey J.E., Woody G.E., and Kleber H.D. Abuse of buprenorphine in the United States: 2003-2005. Journal of Addictive Diseases 26 (2007) 107-111
129. Smith W.R., Penberthy L.T., Bovbjerg V.E., McClish D.K., Roberts J.D., Dahman B., et al. Daily assessment of pain in adults with sickle cell disease. Annals of Internal Medicine 148 (2008) 94-101
130. Sorge J., and Sittl R. Transdermal buprenorphine in the treatment of chronic pain: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clinical Therapy 26 (2004) 1808-1820
131. Strain E.C., and Stitzer M.L. Methadone and other treatments for opioid dependence (2006), Johns Hopkins University Press, Baltimore
132. Streltzer J., and Johansen L. Prescription drug dependence and evolving beliefs about chronic pain management. American Journal of Psychiatry 163 (2006) 594-598
133. Streltzer J., and Kosten T.R. Methadone maintenance therapy and chronic pain. Journal of the American Medical Association 290 (2003) 2403
134. Trescot A.M., Boswell M.V., Atluri S.L., Hansen H.C., Deer T.R., Abdi S., et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 9 (2006) 1-39
135. Trescot A.M., Glaser S.E., Hansen H., Benyamin R., Patel S., and Manchikanti L. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician, Suppl 9 (2008) S1-39
136. Tunis S.R., Stryer D.B., and Clancy C.M. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 290 (2003) 1624-1632
137. Turk D.C., Meichenbaum D., and Genest M. Pain and Behavioral Medicine: A Cognitive Behavioral Prospective (1983), Guilford Press, New York
138. Turk D.C., and Melzack R. The measurement of pain and assessment of people experiencing pain. In: Turk D.C., and Melzack R. (Eds). Handbook of pain assessment. 2nd ed. (2001), Guilford Press, New York 3-14
139. Vallerand A.H. The use of long-acting opioids in chronic pain management. Nursing Clinics of North America 38 (2003) 435-445
140. Verhaak P.F., Kerssens J.J., Dekker J., Sorbi M.J., and Sensing J.M. Prevalence of chronic benign pain disorder among adults: A review of the literature. Pain 77 (1998) 231-239
141. Walsh S.L., Preston K.L., Bigelow G.E., and Stitzer M.L. Acute administration of buprenorphine in humans: Partial agonist and blockade effects. Journal of Pharmacological and Experimental Therapeutics 274 (1995) 361-372
142. Walsh S.L., Preston K.L., Stitzer M.L., Cone E.J., and Bigelow G.E. Clinical pharmacology buprenorphine: Ceiling affects at high dose. Clinical Pharmacology and Therapeutics 55 (1994) 569-580
143. Weissman D.E., and Haddox J.D. Opioid pseudoaddiction: An iatrogenic syndrome. Pain 36 (1989) 363-366
144. White P.F., and Kehlet H. Improving pain management: Are we jumping from the frying pan into the fire?. Anesthesia and Analgesia 105 (2007) 10-12
145. World Health Organization (WHO). Cancer pain relief, with a guide to opioid availability. 2nd ed. (1996), WHO, Geneva
146. Zacny J., Bigelow G., Compton P., Foley K., Iguchi M., and Sannerud C. College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence 69 (2003) 215-232
147. Zbrowski M. People in pain (1969), Jossey-Bass, San Francisco